Odysight.ai Posts 23% Revenue Growth in Aerospace, Defense Shift
Event summary
- 2025 revenue grew 23% YoY to $3.0M, with $1.7M from legacy medical contract wind-down
- $13.8M backlog as of December 31, 2025 provides revenue visibility into 2026
- Completed key aerospace/defense milestones with Israeli Air Force, Italian Air Force, and U.S. flight testing
- Expanded into industrial markets with first commercial order for 200 elevator monitoring systems
- Ended 2025 with $26M cash, no debt after $23.7M Nasdaq offering in February 2025
The big picture
Odysight.ai's transition from medical to aerospace/defense markets reflects broader industry trends toward AI-powered predictive maintenance in high-stakes environments. The $13.8M backlog signals growing adoption, but execution risks remain as the company scales commercial teams and product portfolios. The potential TASE listing could broaden its investor base while navigating public company costs.
What we're watching
- Commercial Momentum
- Whether the $13.8M backlog can convert to revenue at expected rates in 2026
- Market Expansion
- The pace at which Odysight.ai can scale U.S. and EU operations to support global growth
- Strategic Positioning
- How potential TASE dual listing impacts investor access and valuation